Benzinga Florida: Juliana Whitney: CEO & Cannabis Business Consultant: Cann Strategy
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
AYR Wellness Updates Delay of Q1 2025 Interim Filings
LOS ANGELES- AYR Wellness Inc. announced that it did not complete the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, ...
NewLake Capital Partners Declares $0.43 Second Quarter 2025 Dividend
LOS ANGELES- NewLake Capital Partners, Inc. announced on June 16, 2025, that its Board of Directors has approved a cash dividend of $0.43 per share of common stock for the second quarter of 2025. The ...
Israel’s Health Ministry Approves Expansion of Apex Labs’ Phase 2b Psilocybin Trial for PTSD
LOS ANGELES- Apex Labs Ltd. has secured approval from Israel’s Ministry of Health (MoH) and relevant ethics boards to expand its ongoing Phase 2b SUMMIT‑90 clinical trial assessing macrodose psilocybin therapy (APEX‑90) for post-traumatic stress disorder ...
